Haemonetics Corporation (HAE)

Every figure this model derived for HAE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-27.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 36,932,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-27
cash 223,384,000 CashAndCashEquivalentsAtCarryingValue 2026-06-27
current assets 810,832,000 AssetsCurrent 2026-06-27
current liabilities 263,235,000 LiabilitiesCurrent 2026-06-27
equity 837,101,000 StockholdersEquity 2026-06-27
interest expense 19,300,000 InterestExpenseDebt 2026-03-28
ocf 328,149,000 NetCashProvidedByUsedInOperatingActivities 2026-06-27
revenue 1,352,013,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-27
sbc 33,826,000 ShareBasedCompensation 2026-06-27

The ratios

The figures themselves rather than their scores — what somebody looking up HAE on one particular measure came for.

RatioValue
cash operating margin22.24
current ratio3.67
current ratio reported3.08
deferred revenue growth-2.39
dilution pct-6.68
ebit cagr0.14
ebit yoy-29.34
fcf margin21.54
growth cv0.78
interest cover8.12
net debt ebitda3.63
operating margin11.59
owner earnings margin19.04
revenue growth0.44
revenue growth per share7.63
roic6.85
rpo growth-13.89
rule of 4012.04
sbc pct revenue2.5

What to be careful about

What this model itself distrusts about HAE's figures. Written by the derivation as it ran, not added afterwards.